{
    "code": "02011996",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02011996",
    "time": "2020-02-25 10:02:22",
    "許可證字號": "衛署藥輸字第011996號",
    "註銷狀態": "已註銷",
    "註銷日期": "78\/03\/27",
    "註銷理由": "移轉（申請商）",
    "製造許可登錄編號": "",
    "有效日期": "78\/09\/26",
    "發證日期": "72\/12\/01",
    "許可證種類": "製　劑",
    "舊證字號": "13006823",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201199601",
    "中文品名": "強力新明發健針Ｃ",
    "英文品名": "STRONGER NEO C &quot;MINOPHAGEN&quot;",
    "適應症": "維護肝臟正常功能、藥物過敏症、食物過敏",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CYSTEINE, GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL), GLYCYRRHIZINIC ACID (EQ TO GLYCYRRHETINIC ACID GLYCOSIDE)(EQ TO GLYCYRRHIZIC ACID )",
    "限制項目": "02輸　入",
    "申請商名稱": "1211801100  隆進貿易股份有限公司",
    "申請商地址": "台北巿長春路１１５號",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0187000  MINOPHAGEN PHARMACEUTICAL COMPANY",
            "製造廠廠址": "2-7 YOTSUYA 3-CHOME SHINJUKU-KU, TOKYO, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4020100500",
            "成分名稱": "CYSTEINE",
            "含量描述": "0.1",
            "含量": "0.1000000000",
            "單位": "%"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4020102400",
            "成分名稱": "GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL)",
            "含量描述": "2.0",
            "含量": "2.0000000000",
            "單位": "%"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200004600",
            "成分名稱": "GLYCYRRHIZINIC ACID (EQ TO GLYCYRRHETINIC ACID GLYCOSIDE)(EQ TO GLYCYRRHIZIC ACID )",
            "含量描述": "0.2",
            "含量": "0.2000000000",
            "單位": "%"
        }
    ]
}